James George to Purpura, Thrombocytopenic, Idiopathic
This is a "connection" page, showing publications James George has written about Purpura, Thrombocytopenic, Idiopathic.
Connection Strength
11.167
-
Immune Thrombocytopenia Treatment. N Engl J Med. 2021 09 02; 385(10):948-950.
Score: 0.715
-
Treatment of Immune Thrombocytopenia in Adults: Version 2019. Mayo Clin Proc. 2019 11; 94(11):2161-2163.
Score: 0.630
-
Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 10; 91(10):E462-3.
Score: 0.503
-
Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
Score: 0.447
-
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
Score: 0.399
-
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
Score: 0.378
-
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
Score: 0.377
-
Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
Score: 0.370
-
Children with ITP: looking beyond the platelet count. Pediatr Blood Cancer. 2012 Mar; 58(3):323-4.
Score: 0.358
-
Management of immune thrombocytopenia--something old, something new. N Engl J Med. 2010 Nov 11; 363(20):1959-61.
Score: 0.338
-
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
Score: 0.322
-
Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica. 2009 Jun; 94(6):759-62.
Score: 0.306
-
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12; 113(11):2386-93.
Score: 0.294
-
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009 Feb; 144(3):409-15.
Score: 0.294
-
Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006 Aug; 4(8):1664-72.
Score: 0.251
-
Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9.
Score: 0.227
-
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
Score: 0.227
-
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34.
Score: 0.217
-
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
Score: 0.214
-
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20.
Score: 0.211
-
Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. Hematol J. 2004; 5 Suppl 3:S12-4.
Score: 0.210
-
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
Score: 0.208
-
Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep. 2003 Sep; 2(5):381-7.
Score: 0.205
-
Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5.
Score: 0.205
-
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol. 2003 Jun; 73(2):135-40.
Score: 0.202
-
Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk Res. 2002 Sep; 26(9):789-90.
Score: 0.192
-
Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002 Mar; 16(1):37-8.
Score: 0.185
-
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Semin Hematol. 2000 Jul; 37(3):290-8.
Score: 0.165
-
Treatment options for chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol. 2000 Jan; 37(1 Suppl 1):31-4.
Score: 0.159
-
Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):55-61.
Score: 0.159
-
American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 12 10; 3(23):3829-3866.
Score: 0.159
-
Idiopathic thrombocytopenic purpura: diagnosis and management. Am J Med Sci. 1998 Aug; 316(2):87-93.
Score: 0.144
-
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
Score: 0.144
-
Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med. 1998 Feb; 30(1):38-44.
Score: 0.139
-
Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol. 1998 Jan; 35(1 Suppl 1):5-8.
Score: 0.139
-
Clinical decisions in idiopathic thrombocytopenic purpura. Hosp Pract (1995). 1997 Sep 15; 32(9):159-60, 163-6, 169-70, passim.
Score: 0.136
-
Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura. Curr Opin Hematol. 1996 Sep; 3(5):335-40.
Score: 0.126
-
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 01; 88(1):3-40.
Score: 0.125
-
Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1994 Nov 03; 331(18):1207-11.
Score: 0.111
-
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
Score: 0.106
-
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2013 Feb; 90(2):121-6.
Score: 0.098
-
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
Score: 0.087
-
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost. 2010 Jun; 103(6):1203-9.
Score: 0.081
-
Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
Score: 0.077
-
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
Score: 0.076
-
Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009; 153-8.
Score: 0.074
-
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol. 2008 Dec; 83(12):911-5.
Score: 0.074
-
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008 Feb; 83(2):150-4.
Score: 0.070
-
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther. 2007 May; 29(5):950-962.
Score: 0.066
-
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81.
Score: 0.064
-
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol. 2004 Feb; 26(2):146-51.
Score: 0.053
-
Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3.
Score: 0.049